Geron Corporation (GERN) in Focus: Stock Moves 5.6% Higher

Zacks Equity Research


Geron Corporation (GERN) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session.  This reverses the recent downtrend for the company as the stock is now down about 65% since Feb 27.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate has remained unchanged. However, the recent rally high is encouraging, so make sure to keep a close watch on this firm in the near future.

Geron Corporation currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. (ALIOF) and Cambrex Corporation. (CBM) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>






GERON CP (GERN): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report


Zacks Investment Research